NAWAL SULEMAN: Open Payments
NPI 1649927799 · COPPELL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$711 in 22 payments from 10 companies in 2025. Trend: 2023 $118 · 2024 $25 · 2025 $711
Food & beverage: $711
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $280 |
| Novo Nordisk Inc | 6 | $238 |
| Antares Pharma, Inc. | 3 | $59 |
| ABBVIE INC. | 2 | $32 |
| Medtronic, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: FARXIGA, Wegovy, BREZTRI, XYOSTED, Ozempic, UBRELVY, AIRSUPRA, INTELLIS ADAPTIVESTIM.
Industry payments across TX — which companies pay providers there.
